Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • minhduc
    Junior Member
    • Apr 2012
    • 5

    #1

    Help!! Interpret MoDIL results.

    Hi all,

    I have been trying to find indels using MoDIL, but have problems interpreting the results. According to the README file
    Results format is:

    - Cluster ID: Unique ID for each indel prediction
    - Chromosome: Chromosome where the indel is located.
    - Start location: Start location of indel
    - End location: End location of indel
    - Insertion flag: If it is 1, the row means insertion, deletion otherwise.
    - Deletion flag: If it is 1, the row means deletion, insertion otherwise.
    - Size of indel: If it is negative it means deletion, insertion otherwise.
    (ex) -300 => 300bp deletion
    (ex) 12 => 12bp insertion
    - P value: P-value of the indel prediction
    - Likelihood of homozygosity: If it is homozygous, it is close to 1.
    - Number of matepairs that support indel
    - Number of matepairs that support no indel: If it is zero, the indel
    is homozygous
    and a sample output extracted from the predicted INDELs in Yoruban genome, provided in the MoDIL website (http://compbio.cs.toronto.edu/modil/)
    1.0 chr1 218651814 218652002 1 0 75.0 0 1e-09 21220038 0 47 0 25 36 218651906 218651972
    1.0 chr1 102759676 102760211 0 1 -329.0 0 1e-09 10323514 0 67 0 32 37 102759712 102760037
    My interpretation of these results is that there are a 75pb insertion starting at pos 218651814 and ending at pos 218652002, and a 329pb deletion between 102759676 and 102760211. What I don't understand is, in the first line, how an insertion of size 75bp can start at 218651814 and end at 218652002 (i.e., 188 bp apart)? Likewise, in the second line, how a deletion from 102759676 to 102760211 (535 bp in between) can be a 329pb deletion?

    Could anyone please help to explain or to correct my interpretation?

    Thanks
    MD

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...